PortalPublikationenHigh-dose chemotherapy followed by autologous stem cell tran...

High-dose chemotherapy followed by autologous stem cell transplantation for metastatic rhabdomyosarcoma--a systematic review.

  • Frank Peinemann
  • Nicolaus Kröger
  • Carmen Bartel
  • Ulrich Grouven
  • Max Pittler
  • Rudolf Erttmann
  • Michael Kulig

Beteiligte Einrichtungen

Abstract

Patients with metastatic rhabdomyosarcoma (RMS) have a poor prognosis. The aim of this systematic review is to investigate whether high-dose chemotherapy (HDCT) followed by autologous hematopoietic stem cell transplantation (HSCT) in patients with metastatic RMS has additional benefit or harm compared to standard chemotherapy.

Bibliografische Daten

OriginalspracheEnglisch
Aufsatznummer2
ISSN1932-6203
DOIs
StatusVeröffentlicht - 2011
pubmed 21373200